{"id":2518,"date":"2021-03-11T15:12:23","date_gmt":"2021-03-11T07:12:23","guid":{"rendered":"https:\/\/regask.com\/?p=2518"},"modified":"2024-10-26T03:28:45","modified_gmt":"2024-10-25T19:28:45","slug":"richtlinien-fur-die-immunzelltherapie-in-china","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/china-immune-cell-therapy-guidelines\/","title":{"rendered":"China hat technische Richtlinien f\u00fcr klinische Studien herausgegeben."},"content":{"rendered":"<p>China hat technische Richtlinien f\u00fcr klinische Studien mit Produkten der Immunzelltherapie herausgegeben, darunter CAR-T, TCR-T, TIL, CIK usw.<\/p>\n<p>China hat technische Richtlinien f\u00fcr klinische Studien mit Immunzelltherapieprodukten herausgegeben. Diese Richtlinien betreffen g\u00e4ngige Immunzelltherapieprodukte wie CAR-T, TCR-T, TIL, CIK usw.<\/p>\n<p>Als neue Behandlungsform hat die Zelltherapie bahnbrechende Bedeutung in der Behandlung von Krebs und anderen Krankheiten. Stammzellen, Immunzellen und andere somatische Zelltherapietechnologien erzielen nachweislich heilende Wirkungen, die mit Chemotherapeutika und zielgerichteten Medikamenten nicht erreicht werden k\u00f6nnen.<\/p>\n<p>&nbsp;<\/p>\n<a href=\"https:\/\/regask.com\/de\/kontakt\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>Kontaktieren Sie RegASK f\u00fcr weitere Details<\/span>\n\t<\/a>\n\n<a href=\"http:\/\/www.cde.org.cn\/news.do?method=viewInfoCommon&#038;id=9da2b313cd79f360\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Mehr lesen<\/span>\n\t<\/a>","protected":false},"excerpt":{"rendered":"<p>China issued technical guidelines for clinical trials of immune cell therapy products, including CAR-T, TCR-T, TIL, CIK, etc. China issued technical guidelines for clinical trials of immune cell therapy products. These guidelines will affect common immune cell therapy products including CAR-T, TCR-T, TIL, CIK, etc. As a new type of treatment, cell therapy has breakthrough&#8230;<\/p>","protected":false},"author":39,"featured_media":2488,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[514,35],"tags":[40],"class_list":["post-2518","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-china-regulations","category-pharma-biotech-latest-insights","tag-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China: Immune Cell Therapy Clinical Trials | RegASK<\/title>\n<meta name=\"description\" content=\"China issues technical guidelines for clinical trials of immune cell therapy products. Stay informed with RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/richtlinien-fur-die-immunzelltherapie-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China issued technical guidelines for clinical trials of immune cell therapy products\" \/>\n<meta property=\"og:description\" content=\"China issues technical guidelines for clinical trials of immune cell therapy products. Stay informed with RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/richtlinien-fur-die-immunzelltherapie-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T07:12:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-25T19:28:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills-bottle-and-DNA.png\" \/>\n\t<meta property=\"og:image:width\" content=\"688\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"China issued technical guidelines for clinical trials o&hellip;\",\"datePublished\":\"2021-03-11T07:12:23+00:00\",\"dateModified\":\"2024-10-25T19:28:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/\"},\"wordCount\":142,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills-bottle-and-DNA.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"China\",\"Pharma and Biotech\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/\",\"name\":\"China: Immune Cell Therapy Clinical Trials | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills-bottle-and-DNA.png\",\"datePublished\":\"2021-03-11T07:12:23+00:00\",\"dateModified\":\"2024-10-25T19:28:45+00:00\",\"description\":\"China issues technical guidelines for clinical trials of immune cell therapy products. Stay informed with RegASK.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/china-immune-cell-therapy-guidelines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills-bottle-and-DNA.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills-bottle-and-DNA.png\",\"width\":688,\"height\":626,\"caption\":\"Pharma Pills Bottle And DNA\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China: Klinische Studien zur Immunzelltherapie | RegASK","description":"China ver\u00f6ffentlicht technische Richtlinien f\u00fcr klinische Studien mit Immunzelltherapieprodukten. Bleiben Sie mit RegASK auf dem Laufenden.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/richtlinien-fur-die-immunzelltherapie-in-china\/","og_locale":"de_DE","og_type":"article","og_title":"China issued technical guidelines for clinical trials of immune cell therapy products","og_description":"China issues technical guidelines for clinical trials of immune cell therapy products. Stay informed with RegASK.","og_url":"https:\/\/regask.com\/de\/richtlinien-fur-die-immunzelltherapie-in-china\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2021-03-11T07:12:23+00:00","article_modified_time":"2024-10-25T19:28:45+00:00","og_image":[{"width":688,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills-bottle-and-DNA.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/#article","isPartOf":{"@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"China issued technical guidelines for clinical trials o&hellip;","datePublished":"2021-03-11T07:12:23+00:00","dateModified":"2024-10-25T19:28:45+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/"},"wordCount":142,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills-bottle-and-DNA.png","keywords":["Latest Insights"],"articleSection":["China","Pharma and Biotech"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/","url":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/","name":"China: Klinische Studien zur Immunzelltherapie | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills-bottle-and-DNA.png","datePublished":"2021-03-11T07:12:23+00:00","dateModified":"2024-10-25T19:28:45+00:00","description":"China ver\u00f6ffentlicht technische Richtlinien f\u00fcr klinische Studien mit Immunzelltherapieprodukten. Bleiben Sie mit RegASK auf dem Laufenden.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/china-immune-cell-therapy-guidelines\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills-bottle-and-DNA.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills-bottle-and-DNA.png","width":688,"height":626,"caption":"Pharma Pills Bottle And DNA"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Intelligentere Regulierungsentscheidungen erm\u00f6glichen","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/2518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=2518"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/2518\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/2488"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=2518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=2518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=2518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}